Hims & Hers shares tumble as margin miss adds to concerns about GLP-1 business
Hims & Hers Health reported fourth-quarter results on Monday that beat analysts’ expectations, but the stock sank in extended ...
Hims & Hers Health (NYSE:HIMS) Beats Q4 Sales Targets But Stock Drops 16%
Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q4 CY2024, with sales up 95.1% ...
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December ...
Hims & Hers Health 4Q Revenue Surges on Boost From Weight-Loss Treatments
Revenue excluding its GLP-1 offering increased 43% to $1.2 billion in 2024 from a year earlier, said Chief Financial Officer Yemi Okupe. Including sales of its weight-loss treatments, revenue surged ...
Hims & Hers reports Q4 EPS 11c, consensus 22c
Reports Q4 revenue $481.1M, consensus $470.5M. “2024 was a fantastic year at Hims and Hers as we continue to build a platform that leverages ...
Investor's Business Daily on MSN30m
IBD 50's No. 2, Hims & Hers, Crashes 15% Despite Upbeat Earnings
Compounding pharmacy and IBD 50 newcomer Hims & Hers Health reported bullish earnings and sales growth late Monday. But Hims ...